Blockade of Experimental Atopic Dermatitis via Topical NF-κB Decoy Oligonucleotide
Open Access
- 1 August 2006
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 126 (8) , 1792-1803
- https://doi.org/10.1038/sj.jid.5700307
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- The carcinogenic potential of tacrolimus ointment beyond immune suppression: a hypothesis creating case reportBMC Cancer, 2006
- Evidence that anti–tumor necrosis factor therapy with both etanercept and infliximab induces apoptosis in macrophages, but not lymphocytes, in rheumatoid arthritis joints: Extended reportArthritis & Rheumatism, 2005
- Dichotomy of glucocorticoid action in the immune systemTrends in Immunology, 2002
- Pathophysiologic mechanisms in atopic dermatitisSeminars in Cutaneous Medicine and Surgery, 2001
- Anti-inflammatory Actions of Glucocorticoids: Molecular MechanismsClinical Science, 1998
- Nuclear Factor-κB — A Pivotal Transcription Factor in Chronic Inflammatory DiseasesNew England Journal of Medicine, 1997
- Fusigenic viral liposome for gene therapy in cardiovascular diseases.Proceedings of the National Academy of Sciences, 1996
- Effects of an inhaled steroid (budesonide) on skin collagen synthesis of asthma patients in vivo.American Journal of Respiratory and Critical Care Medicine, 1996
- Allergic contact dermatitis in the domestic pig. A new model for evaluating the topical anti-inflammatory activity of drugs and their formulationsBritish Journal of Dermatology, 1984
- Steroid‐induced Dermal AtrophyInternational Journal of Dermatology, 1982